Kyowa Hakko Kirin Pharma, Inc.
21
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
19.0%
4 terminated/withdrawn out of 21 trials
80.0%
-6.5% vs industry average
10%
2 trials in Phase 3/4
50%
8 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Role: collaborator
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Role: collaborator
Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
Role: collaborator
A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease
Role: collaborator
A Study of KRN23 in X-linked Hypophosphatemia
Role: collaborator
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Role: collaborator
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Role: collaborator
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Role: collaborator
Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
Role: collaborator
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Role: collaborator
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
Role: collaborator
Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
Role: collaborator
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Role: collaborator
A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Role: collaborator
Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
Role: collaborator
The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
Role: collaborator
A Study to Evaluate Abuse Potential of Istradefylline
Role: collaborator
Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
Role: collaborator
Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline
Role: collaborator
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
Role: collaborator